Full Text
Early Market Access for Pharmaceuticals in EU- What is the Impact of Ema’s Accelerated Assessment Procedure?

Abstract

Authors

L Parviainen W Belgaied Y Sediri B Haijeji C Rémuzat M Toumi

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×